Business Context and Reporting Period
Myomo, Inc., a Delaware corporation, filed this Form 8-K on November 30, 2017, to report the entry into a Material Definitive Agreement. The Company is an emerging growth company headquartered in Cambridge, Massachusetts.
Key Financial Metrics and Transaction Details
This filing details a public offering rather than periodic financial performance metrics. Key transaction figures include:
- Shares Offered: 4,175,000 shares of Common Stock.
- Investor Warrants: Warrants to purchase 4,175,000 shares of Common Stock (one warrant per share).
- Public Offering Price: $2.40 per share of Common Stock and accompanying Investor Warrant.
- Underwriter Purchase Price: $2.256 per unit (a 6.0% discount to the public price).
- Expected Net Proceeds: Approximately $9.1 million, assuming no exercise of Investor Warrants and after deducting underwriting discounts, commissions, and transaction expenses.
- Over-Allotment Option: The underwriter has a 45-day option to purchase up to an additional 626,250 shares and/or warrants.
- Warrant Terms: Investor Warrants are exercisable immediately, expire in five years, and have an exercise price of $2.95 per share. They include full ratchet anti-dilution protection.
Material Changes and Agreements
The primary material change is the execution of an underwriting agreement with Roth Capital Partners, LLC. The Company has agreed to a 90-day lock-up period, during which it cannot offer, issue, or sell additional Common Stock or convertible securities without the underwriter's consent. Additionally, the Company issued an Underwriter Warrant to purchase 1% of the shares sold in the offering at an exercise price of $2.40, exercisable after six months and expiring in three years.
Guidance, Outlook, and Risks
The filing does not provide forward-looking financial guidance or management commentary on operational outlook. The closing of the offering is expected on December 4, 2017, subject to customary closing conditions. Risks associated with the transaction include the dilutive effect of the Investor Warrants and the Underwriter Warrant, as well as the full ratchet anti-dilution provisions which could significantly adjust the exercise price if the Company issues stock at a lower price in the future.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected December 4, 2017) and the final net proceeds received.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific representations and warranties.
- Monitor the Company's capital structure for any future issuances that would trigger the full ratchet anti-dilution adjustment on the Investor Warrants.
- Confirm the status of the over-allotment option exercise by the underwriter within the 45-day window.